Alternating Hemiplegia of Childhood: gastrointestinal manifestations and correlation with neurological impairments.
ATP1A3
Alternating hemiplegia of childhood
GMFCS
Non-paroxysmal disability index
Journal
Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602
Informations de publication
Date de publication:
03 09 2020
03 09 2020
Historique:
received:
13
01
2020
accepted:
21
07
2020
entrez:
5
9
2020
pubmed:
5
9
2020
medline:
22
6
2021
Statut:
epublish
Résumé
Alternating Hemiplegia of Childhood (AHC) is caused by mutations of the ATP1A3 gene which is expressed in brain areas that include structures controling autonomic, gastrointestinal, gut motility and GABAergic functions. We aimed to investigate, in a cohort of 44 consecutive AHC patients, two hypotheses: 1) AHC patients frequently manifest gastrointestinal, particularly motility, problems. 2) These problems are often severe and their severity correlates with neurological impairments. 41/44 (93%) exhibited gastrointestinal symptoms requiring medical attention. For these 41 patients, symptoms included constipation (66%), swallowing problems (63%), vomiting (63%), anorexia (46%), diarrhea (44%), nausea (37%), and abdominal pain (22%). Symptoms indicative of dysmotility occurred in 33 (80%). The most common diagnoses were oropharyngeal dysphagia (63%) and gastroesophageal reflux (63%). 16 (39%) required gastrostomy and two fundoplication. Severity of gastrointestinal symptoms correlated with non-paroxysmal neurological disability index, Gross Motor Function Classification System scores, and with the presence/absence of non-gastrointestinal autonomic dysfunction (p = 0.031, 0.043, Spearman correlations and 0.0166 Cramer's V, respectively) but not with the paroxysmal disability index (p = 0.408). Most AHC patients have gastrointestinal problems. These are usually severe, most commonly are indicative of dysmotility, often require surgical therapies, and their severity correlates with that of non-paroxysmal CNS manifestations. Our findings should help in management-anticipatory guidance of AHC patients. Furthermore, they are consistent with current understandings of the pathophysiology of AHC and of gastrointestinal dysmotility, both of which involve autonomic and GABAergic dysfunction.
Sections du résumé
BACKGROUND
Alternating Hemiplegia of Childhood (AHC) is caused by mutations of the ATP1A3 gene which is expressed in brain areas that include structures controling autonomic, gastrointestinal, gut motility and GABAergic functions. We aimed to investigate, in a cohort of 44 consecutive AHC patients, two hypotheses: 1) AHC patients frequently manifest gastrointestinal, particularly motility, problems. 2) These problems are often severe and their severity correlates with neurological impairments.
RESULTS
41/44 (93%) exhibited gastrointestinal symptoms requiring medical attention. For these 41 patients, symptoms included constipation (66%), swallowing problems (63%), vomiting (63%), anorexia (46%), diarrhea (44%), nausea (37%), and abdominal pain (22%). Symptoms indicative of dysmotility occurred in 33 (80%). The most common diagnoses were oropharyngeal dysphagia (63%) and gastroesophageal reflux (63%). 16 (39%) required gastrostomy and two fundoplication. Severity of gastrointestinal symptoms correlated with non-paroxysmal neurological disability index, Gross Motor Function Classification System scores, and with the presence/absence of non-gastrointestinal autonomic dysfunction (p = 0.031, 0.043, Spearman correlations and 0.0166 Cramer's V, respectively) but not with the paroxysmal disability index (p = 0.408).
CONCLUSIONS
Most AHC patients have gastrointestinal problems. These are usually severe, most commonly are indicative of dysmotility, often require surgical therapies, and their severity correlates with that of non-paroxysmal CNS manifestations. Our findings should help in management-anticipatory guidance of AHC patients. Furthermore, they are consistent with current understandings of the pathophysiology of AHC and of gastrointestinal dysmotility, both of which involve autonomic and GABAergic dysfunction.
Identifiants
pubmed: 32883312
doi: 10.1186/s13023-020-01474-w
pii: 10.1186/s13023-020-01474-w
pmc: PMC7469407
doi:
Substances chimiques
ATP1A3 protein, human
0
Sodium-Potassium-Exchanging ATPase
EC 7.2.2.13
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
231Subventions
Organisme : NICHD NIH HHS
ID : R25 HD082842
Pays : United States
Références
Brain Res. 1991 Apr 12;546(1):47-54
pubmed: 1649668
J Pediatr Gastroenterol Nutr. 2002 Sep;35(3):377-83
pubmed: 12352533
Neuropathol Appl Neurobiol. 2016 Feb;42(2):180-93
pubmed: 25786813
Epilepsia. 2018 Jul;59(7):1455-1468
pubmed: 29889309
Eur J Paediatr Neurol. 2019 May;23(3):345-346
pubmed: 31178018
Am J Physiol Endocrinol Metab. 2015 Aug 15;309(4):E320-33
pubmed: 26081283
Neurology. 2014 Feb 11;82(6):482-90
pubmed: 24431296
Dev Med Child Neurol. 1980 Dec;22(6):784-91
pubmed: 7450304
Lancet Neurol. 2014 May;13(5):503-14
pubmed: 24739246
Nature. 2010 Nov 11;468(7321):263-9
pubmed: 21068835
Brain. 2010 Dec;133(Pt 12):3598-610
pubmed: 20974617
Neuroscience. 2019 Feb 1;398:274-294
pubmed: 30031123
Orphanet J Rare Dis. 2015 Sep 26;10:123
pubmed: 26410222
Int Rev Neurobiol. 2011;97:207-25
pubmed: 21708312
Neurology. 1992 Dec;42(12):2251-7
pubmed: 1361034
Neurogastroenterol Motil. 2013 Apr;25(4):313-e249
pubmed: 23279161
Curr Treat Options Neurol. 2017 Feb;19(2):8
pubmed: 28337648
Neurobiol Dis. 2018 Nov;119:100-112
pubmed: 30071271
Epilepsia. 2015 Jan;56(1):82-93
pubmed: 25523819
Endocrine. 2015 Nov;50(2):276-91
pubmed: 26089260
Neurology. 2019 Sep 24;93(13):e1248-e1259
pubmed: 31484714
Brain Dev. 1999 Jul;21(5):307-11
pubmed: 10413017
Eur J Paediatr Neurol. 2020 May;26:15-19
pubmed: 32115366
Pediatr Neurol. 2000 Aug;23(2):134-41
pubmed: 11020638
Neuroscience. 2003;116(4):1069-80
pubmed: 12617948
PLoS One. 2014 May 19;9(5):e97274
pubmed: 24842602
J Cell Physiol. 2017 Sep;232(9):2359-2372
pubmed: 27512962
J Pediatr Gastroenterol Nutr. 2014 Feb;58(2):237-44
pubmed: 24121144
PLoS One. 2015 May 21;10(5):e0127045
pubmed: 25996915
Dev Med Child Neurol. 2019 May;61(5):547-554
pubmed: 30362107
Front Biosci. 2005 Sep 01;10:2373-96
pubmed: 15970502
Dev Med Child Neurol. 2017 Aug;59(8):822-828
pubmed: 28543714
J Comp Neurol. 2011 Feb 1;519(2):376-404
pubmed: 21165980